We hypothesized that the use of an Action Plan might assist self-management for patients with chronic obstructive pulmonary disease (COPD).
A pilot process and randomized, controlled study were undertaken to evaluate an Action Plan that provided advice on management of usual care and exacerbations, together with a booklet on self-management.
Fifty six subjects with COPD recruited through general practitioners (GPs) completed the 6 month study, 27 in the control group and 29 in the intervention group.
The control group received usual care from their GP, and the intervention group received a booklet and Action Plan from their practice nurse plus a supply of prednisone and antibiotic from their GP.
The two groups were demographically similar with a mean age of 68 yrs.
The resources were well received by GPs, practice nurses and intervention group sub jects.
After 6 months, there were no differences in quality of life scores or pulmonary function.
There were significant changes in self-management behaviour in the intervention group compared to controls.
In response to deteriorating symptoms, 34 versus 7% (p=0.014) initiated prednisone treatment and 44 versus 7% (p-0.002) initiated antibiotics.
Subjects in the intervention group readily adopted self-management skills but did not show any difference in quality of life or lung function parameters.
A larger, prospective, controlled, clinical trial of this approach is warranted.
Mots-clés Pascal : Bronchopneumopathie obstructive, Chronique, Prednisone, Bronchodilatateur, Chimiothérapie, Education santé, Autoadministration, Qualité vie, Fonction respiratoire, Traitement, Exploration, Evolution, Adulte, Homme, Nouvelle Zélande, Océanie, Corticostéroïde, Appareil respiratoire pathologie, Poumon pathologie, Bronche pathologie
Mots-clés Pascal anglais : Obstructive pulmonary disease, Chronic, Prednisone, Bronchodilator, Chemotherapy, Health education, Self administration, Quality of life, Lung function, Treatment, Exploration, Evolution, Adult, Human, New Zealand, Oceania, Corticosteroid, Respiratory disease, Lung disease, Bronchus disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0350272
Code Inist : 002B02D. Création : 12/09/1997.